Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A clinical study on cefdinir in pediatrics].

Y Satoh1, S Iwata, H Akita

  • 1Department of Pediatrics, Ohta General Hospital.

The Japanese Journal of Antibiotics
|October 1, 1990
PubMed
Summary

Cefdinir (CFDN) demonstrated an 88% efficacy rate in treating pediatric infections, with a low incidence of side effects. This suggests CFDN is a safe and effective antibiotic option for children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non-small-cell lung cancer: The global, multicenter EXPRESS study.

Lung cancer (Amsterdam, Netherlands)·2019
Same author

Appropriate management of high-flow priapism based on color Doppler ultrasonography findings in pediatric patients: four case reports and a review of the literature.

Journal of pediatric urology·2019
Same author

FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

ESMO open·2016
Same author

Anatomical versus non-anatomical resection for hepatocellular carcinoma.

The British journal of surgery·2015

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacology
  • Antimicrobial Therapy

Background:

  • Pediatric infections pose a significant public health challenge.
  • Evaluating novel antimicrobial agents for pediatric use is crucial.
  • Cefdinir (CFDN) is a third-generation cephalosporin antibiotic.

Purpose of the Study:

  • To assess the clinical efficacy and safety of cefdinir (CFDN) in pediatric patients.
  • To evaluate the bacteriological eradication rates associated with CFDN treatment.
  • To document adverse events and abnormal laboratory findings during CFDN therapy.

Main Methods:

  • Clinical evaluations were conducted on 43 pediatric patients with various infections.
  • Bacteriological assessments included evaluating eradication rates for 34 pathogen isolates.
  • Adverse events and laboratory parameters were monitored throughout the study.

Main Results:

  • An overall clinical efficacy rate of 88% was observed (23 excellent, 15 good, 4 fair).
  • The bacteriological eradication rate for targeted pathogens was 85.3%.
  • Diarrhea occurred in 8.3% of patients; abnormal lab findings included elevated GOT, eosinophils, and platelets.

Conclusions:

  • Cefdinir (CFDN) exhibits high clinical efficacy and a favorable safety profile in treating pediatric infections.
  • The drug achieved significant bacteriological eradication, supporting its effectiveness against common pediatric pathogens.
  • CFDN is a promising and safe therapeutic option for managing infections in pediatric populations.

Related Experiment Videos